(PQD6) Hypothalamic Inflammation in the Initiation of Cachexia
(PQD6) Hypothalamic Inflammation in the Initiation of Cachexia
批准号:
8994016
负责人:
Daniel L. Marks
金额:
$10.0万
依托单位国家:
美国
项目类别:
财政年份:
2014
资助国家:
美国
项目状态:
已结题
起止时间:
2014-07-01 至 2018-06-30
关键词:
AcuteAdrenal GlandsAnorexiaBehaviorBehavioralBody Weight decreasedCachexiaCancer PatientCatabolismCessation of lifeChronicChronic DiseaseClinicalCollaborationsCommunicable DiseasesCytokine ReceptorsDataDevelopmentDiseaseEventFatigueFatty acid glycerol estersGenesGlycoproteinsGoalsHealthHomeostasisHypothalamic structureInflammationInflammatoryInterferonsInterventionKidney FailureLaboratoriesLeukocytesLifeLinkLymphocyteMaintenanceMalignant NeoplasmsMalnutritionMetabolicMetabolismMicrogliaModelingMorbidity - disease rateMuscleMyelogenousNeuroendocrinologyNeuronsNeurosciencesOutputPathologyPatientsPeripheralPharmacologic SubstancePlayPopulationPublishingQuality of lifeResearchResearch DesignRiskRoleSeveritiesSignal PathwaySignal TransductionTherapeutic InterventionWorkcancer cachexiachemokinehypocretinincreased appetitelean body masslipid metabolismmortalityresponsesignal processingtumor progressionwasting
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Cachexia, or disease-associated wasting, is a common occurrence in cancer, renal failure, and infectious disease. This devastating state of malnutrition is brought about by a synergistic combination of a decrease in appetite and an increase in metabolism of fat and lean body mass. The severity of cachexia in many illnesses is the primary determining factor in both quality of life, and in eventual mortality. Other illness-induced morbidities including lethargy also compromise the ability of patients to recover from potentially life-saving or extending interventions, and diminish the motivational drive to aggressively battle the condition. Although cachexia in chronic disease was described more than two thousand years ago, the central mechanisms underlying this disorder of energy homeostasis are poorly understood. Furthermore, there is currently no effective pharmaceutical treatment. Our laboratory has dedicated the last decade to unraveling the basic neuroscience of cachexia. In this proposal, we will focus on understanding the scope and mechanism by which peripheral inflammatory insults are received, amplified, and maintained by the hypothalamus. The significance of this proposal resides in its unique combination of our historical focus on neuroendocrinology and behavior, with new collaborations and efforts directed at understanding proximal neuroinflammatory events. The long-term goal of our research is to gain mechanistic understanding of the acute illness response and how it is transitioned into chronic inflammation-associated cachexia in order to develop more effective therapeutic interventions.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
PQ6: Therapeutic approaches for autonomic and neuroendocrine dysfunction in cancer cachexia
-
批准号:10303658
-
项目类别:
-
资助金额:$43.28万
-
财政年份:2021
-
负责人:Daniel L. Marks
-
依托单位:
PQ6: Lipocalin-2 as a therapeutic target for prevention of cancer cachexia
-
批准号:10379260
-
项目类别:
-
资助金额:$38.58万
-
财政年份:2021
-
负责人:Daniel L. Marks
-
依托单位:
PQ6: Lipocalin-2 as a therapeutic target for prevention of cancer cachexia
-
批准号:10152268
-
项目类别:
-
资助金额:$39.37万
-
财政年份:2021
-
负责人:Daniel L. Marks
-
依托单位:
PQ6: Therapeutic approaches for autonomic and neuroendocrine dysfunction in cancer cachexia
-
批准号:10490306
-
项目类别:
-
资助金额:$42.41万
-
财政年份:2021
-
负责人:Daniel L. Marks
-
依托单位:
Exosomes as Endocrine Signaling Molecules in Cancer Cachexia
-
批准号:9906180
-
项目类别:
-
资助金额:$43.98万
-
财政年份:2018
-
负责人:Daniel L. Marks
-
依托单位:
Exosomes as Endocrine Signaling Molecules in Cancer Cachexia
-
批准号:10171402
-
项目类别:
-
资助金额:$43.98万
-
财政年份:2018
-
负责人:Daniel L. Marks
-
依托单位:
Exosomes as Endocrine Signaling Molecules in Cancer Cachexia
-
批准号:10394305
-
项目类别:
-
资助金额:$43.1万
-
财政年份:2018
-
负责人:Daniel L. Marks
-
依托单位:
(PQD6) Hypothalamic Inflammation in the Initiation of Cachexia
-
批准号:8845181
-
项目类别:
-
资助金额:$42.24万
-
财政年份:2014
-
负责人:Daniel L. Marks
-
依托单位:
(PQD6) Hypothalamic Inflammation in the Initiation of Cachexia
-
批准号:9079439
-
项目类别:
-
资助金额:$42.24万
-
财政年份:2014
-
负责人:Daniel L. Marks
-
依托单位:
(PQD6) Hypothalamic Inflammation in the Initiation of Cachexia
-
批准号:8680933
-
项目类别:
-
资助金额:$42.24万
-
财政年份:2014
-
负责人:Daniel L. Marks
-
依托单位:
EVOLUTION OF INSULIN RESISTANCE
-
批准号:7206608
-
项目类别:
-
资助金额:$0.5万
-
财政年份:2005
-
负责人:Daniel L. Marks
-
依托单位:
Hypothalamic Mechanisms in Cachexia
-
批准号:8058687
-
项目类别:
-
资助金额:$31.98万
-
财政年份:2004
-
负责人:Daniel L. Marks
-
依托单位:
Hypothalamic Mechanisms in Cachexia
-
批准号:7885233
-
项目类别:
-
资助金额:$38.5万
-
财政年份:2004
-
负责人:Daniel L. Marks
-
依托单位:
Hypothalamic Mechanisms in Cachexia
-
批准号:7920640
-
项目类别:
-
资助金额:$7.5万
-
财政年份:2004
-
负责人:Daniel L. Marks
-
依托单位:
Hypothalamic Mechanisms in Cachexia
-
批准号:6900231
-
项目类别:
-
资助金额:$24.66万
-
财政年份:2004
-
负责人:Daniel L. Marks
-
依托单位:
Hypothalamic Mechanisms in Cachexia
-
批准号:7235331
-
项目类别:
-
资助金额:$25.06万
-
财政年份:2004
-
负责人:Daniel L. Marks
-
依托单位:
Hypothalamic Mechanisms in Cachexia
-
批准号:8441602
-
项目类别:
-
资助金额:$30.86万
-
财政年份:2004
-
负责人:Daniel L. Marks
-
依托单位:
Hypothalamic Mechanisms in Cachexia
-
批准号:7068044
-
项目类别:
-
资助金额:$25.06万
-
财政年份:2004
-
负责人:Daniel L. Marks
-
依托单位:
Hypothalamic Mechanisms in Cachexia
-
批准号:8249437
-
项目类别:
-
资助金额:$31.98万
-
财政年份:2004
-
负责人:Daniel L. Marks
-
依托单位:
Hypothalamic Mechanisms in Cachexia
-
批准号:7429671
-
项目类别:
-
资助金额:$25.3万
-
财政年份:2004
-
负责人:Daniel L. Marks
-
依托单位:
海外基金